Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Coronary Artery Disease: HELP
Articles by Philippe Kolh
Based on 27 articles published since 2010
(Why 27 articles?)
||||

Between 2010 and 2020, Philippe Kolh wrote the following 27 articles about Coronary Artery Disease.
 
+ Citations + Abstracts
Pages: 1 · 2
1 Guideline 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. 2018

Valgimigli, Marco / Bueno, Héctor / Byrne, Robert A / Collet, Jean-Philippe / Costa, Francesco / Jeppsson, Anders / Jüni, Peter / Kastrati, Adnan / Kolh, Philippe / Mauri, Laura / Montalescot, Gilles / Neumann, Franz-Josef / Petricevic, Mate / Roffi, Marco / Steg, Philippe Gabriel / Windecker, Stephan / Zamorano, Jose Luis / Levine, Glenn N / Anonymous7100923. · ·Eur J Cardiothorac Surg · Pubmed #29045581.

ABSTRACT: -- No abstract --

2 Guideline 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). 2018

Valgimigli, Marco / Bueno, Héctor / Byrne, Robert A / Collet, Jean-Philippe / Costa, Francesco / Jeppsson, Anders / Jüni, Peter / Kastrati, Adnan / Kolh, Philippe / Mauri, Laura / Montalescot, Gilles / Neumann, Franz-Josef / Petricevic, Mate / Roffi, Marco / Steg, Philippe Gabriel / Windecker, Stephan / Zamorano, Jose Luis / Levine, Glenn N / Anonymous4980918 / Anonymous4990918 / Anonymous5000918. · ·Eur Heart J · Pubmed #28886622.

ABSTRACT: -- No abstract --

3 Guideline [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] 2017

Valgimigli, Marco / Bueno, Héctor / Byrne, Robert A / Collet, Jean-Philippe / Costa, Francesco / Jeppsson, Anders / Jüni, Peter / Kastrati, Adnan / Kolh, Philippe / Mauri, Laura / Montalescot, Gilles / Neumann, Franz-Josef / Peticevic, Mate / Roffi, Marco / Steg, Philippe Gabriel / Windecker, Stephan / Zamorano, Jose Luis. ·Cardiology, Inselspital, Bern. marco.valgimigli@insel.ch. ·Kardiol Pol · Pubmed #29251754.

ABSTRACT: -- No abstract --

4 Guideline Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading? 2015

Costa, Francesco / Ariotti, Sara / Valgimigli, Marco / Kolh, Philippe / Windecker, Stephan / Anonymous4370830. ·Thoraxcenter, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. ·J Cardiovasc Transl Res · Pubmed #25986910.

ABSTRACT: The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings. The 2014 document updates and extends the effort started in 2010, year of the first edition of these guidelines. Importantly, this latest edition provides a systematic review of all randomized clinical trials performed since 1980, comparing different strategies of myocardial revascularization, including coronary artery bypass graft (CABG), balloon angioplasty, percutaneous coronary intervention (PCI) with bare-metal stents (BMS) and first- and second-generation drug-eluting stents (DES). This review aims to highlight the most relevant novelties introduced by the 2014 edition of the ESC/EACTS myocardial revascularization guidelines as compared with the previous edition and to describe similarities and differences with the American societies' guidelines.

5 Guideline 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). 2014

Kolh, Philippe / Windecker, Stephan / Alfonso, Fernando / Collet, Jean-Philippe / Cremer, Jochen / Falk, Volkmar / Filippatos, Gerasimos / Hamm, Christian / Head, Stuart J / Jüni, Peter / Kappetein, A Pieter / Kastrati, Adnan / Knuuti, Juhani / Landmesser, Ulf / Laufer, Günther / Neumann, Franz-Josef / Richter, Dimitrios J / Schauerte, Patrick / Sousa Uva, Miguel / Stefanini, Giulio G / Taggart, David Paul / Torracca, Lucia / Valgimigli, Marco / Wijns, William / Witkowski, Adam / Anonymous7870804 / Zamorano, Jose Luis / Achenbach, Stephan / Baumgartner, Helmut / Bax, Jeroen J / Bueno, Héctor / Dean, Veronica / Deaton, Christi / Erol, Çetin / Fagard, Robert / Ferrari, Roberto / Hasdai, David / Hoes, Arno W / Kirchhof, Paulus / Knuuti, Juhani / Kolh, Philippe / Lancellotti, Patrizio / Linhart, Ales / Nihoyannopoulos, Petros / Piepoli, Massimo F / Ponikowski, Piotr / Sirnes, Per Anton / Tamargo, Juan Luis / Tendera, Michal / Torbicki, Adam / Wijns, William / Windecker, Stephan / Anonymous7880804 / Sousa Uva, Miguel / Achenbach, Stephan / Pepper, John / Anyanwu, Anelechi / Badimon, Lina / Bauersachs, Johann / Baumbach, Andreas / Beygui, Farzin / Bonaros, Nikolaos / De Carlo, Marco / Deaton, Christi / Dobrev, Dobromir / Dunning, Joel / Eeckhout, Eric / Gielen, Stephan / Hasdai, David / Kirchhof, Paulus / Luckraz, Heyman / Mahrholdt, Heiko / Montalescot, Gilles / Paparella, Domenico / Rastan, Ardawan J / Sanmartin, Marcelo / Sergeant, Paul / Silber, Sigmund / Tamargo, Juan / ten Berg, Jurrien / Thiele, Holger / van Geuns, Robert-Jan / Wagner, Hans-Otto / Wassmann, Sven / Wendler, Olaf / Zamorano, Jose Luis / Anonymous7890804 / Anonymous7900804. ·(Belgium) philippe.kolh@chu.ulg.ac.be stephan.windecker@insel.ch. · (Switzerland) philippe.kolh@chu.ulg.ac.be stephan.windecker@insel.ch. · (Spain). · (France). · (Germany). · (Switzerland). · (Greece). · (Netherlands). · (Finland). · (Austria). · (Portugal). · (UK). · (Italy). · (Belgium). · (Poland). · (Turkey). · (Israel). · (Germany/UK). · (Czech Republic). · (Norway). · (USA). · (UK/Germany). ·Eur J Cardiothorac Surg · Pubmed #25173601.

ABSTRACT: -- No abstract --

6 Guideline 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). 2014

Anonymous7760804 / Windecker, Stephan / Kolh, Philippe / Alfonso, Fernando / Collet, Jean-Philippe / Cremer, Jochen / Falk, Volkmar / Filippatos, Gerasimos / Hamm, Christian / Head, Stuart J / Jüni, Peter / Kappetein, A Pieter / Kastrati, Adnan / Knuuti, Juhani / Landmesser, Ulf / Laufer, Günther / Neumann, Franz-Josef / Richter, Dimitrios J / Schauerte, Patrick / Sousa Uva, Miguel / Stefanini, Giulio G / Taggart, David Paul / Torracca, Lucia / Valgimigli, Marco / Wijns, William / Witkowski, Adam. · ·Eur Heart J · Pubmed #25173339.

ABSTRACT: -- No abstract --

7 Guideline 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013

Anonymous21063 / Montalescot, Gilles / Sechtem, Udo / Achenbach, Stephan / Andreotti, Felicita / Arden, Chris / Budaj, Andrzej / Bugiardini, Raffaele / Crea, Filippo / Cuisset, Thomas / Di Mario, Carlo / Ferreira, J Rafael / Gersh, Bernard J / Gitt, Anselm K / Hulot, Jean-Sebastien / Marx, Nikolaus / Opie, Lionel H / Pfisterer, Matthias / Prescott, Eva / Ruschitzka, Frank / Sabaté, Manel / Senior, Roxy / Taggart, David Paul / van der Wall, Ernst E / Vrints, Christiaan J M / Anonymous31063 / Zamorano, Jose Luis / Achenbach, Stephan / Baumgartner, Helmut / Bax, Jeroen J / Bueno, Héctor / Dean, Veronica / Deaton, Christi / Erol, Cetin / Fagard, Robert / Ferrari, Roberto / Hasdai, David / Hoes, Arno W / Kirchhof, Paulus / Knuuti, Juhani / Kolh, Philippe / Lancellotti, Patrizio / Linhart, Ales / Nihoyannopoulos, Petros / Piepoli, Massimo F / Ponikowski, Piotr / Sirnes, Per Anton / Tamargo, Juan Luis / Tendera, Michal / Torbicki, Adam / Wijns, William / Windecker, Stephan / Anonymous41063 / Knuuti, Juhani / Valgimigli, Marco / Bueno, Héctor / Claeys, Marc J / Donner-Banzhoff, Norbert / Erol, Cetin / Frank, Herbert / Funck-Brentano, Christian / Gaemperli, Oliver / Gonzalez-Juanatey, José R / Hamilos, Michalis / Hasdai, David / Husted, Steen / James, Stefan K / Kervinen, Kari / Kolh, Philippe / Kristensen, Steen Dalby / Lancellotti, Patrizio / Maggioni, Aldo Pietro / Piepoli, Massimo F / Pries, Axel R / Romeo, Francesco / Rydén, Lars / Simoons, Maarten L / Sirnes, Per Anton / Steg, Ph Gabriel / Timmis, Adam / Wijns, William / Windecker, Stephan / Yildirir, Aylin / Zamorano, Jose Luis. ·The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines. ·Eur Heart J · Pubmed #23996286.

ABSTRACT: -- No abstract --

8 Editorial Transatlantic Editorial: A Comparison Between European and North American Guidelines on Myocardial Revascularization. 2016

Kolh, Philippe / Kurlansky, Paul / Cremer, Jochen / Lawton, Jennifer / Siepe, Matthias / Fremes, Stephen. ·Cardiovascular Surgery Department, University Hospital (CHU, ULg) of Liège, Liège, Belgium. Electronic address: philippe.kolh@chu.ulg.ac.be. · Center for Innovation and Outcomes Research, Columbia University, New York, New York. · Cardiovascular Surgery Department, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri. · Department of Cardiovascular Surgery, University Heart Centre Freiburg Bad Krozingen, Bad Krozingen, Germany. · Division of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. ·Ann Thorac Surg · Pubmed #27139371.

ABSTRACT: -- No abstract --

9 Editorial Transatlantic Editorial: a comparison between European and North American guidelines on myocardial revascularization. 2016

Kolh, Philippe / Kurlansky, Paul / Cremer, Jochen / Lawton, Jennifer / Siepe, Matthias / Fremes, Stephen. ·Cardiovascular Surgery Department, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. · Center for Innovation and Outcomes Research, Columbia University, New York, NY, USA. · Cardiovascular Surgery Department, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Cardiovascular Surgery, University Heart Centre Freiburg Bad Krozingen, Bad Krozingen, Germany. · Division of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. ·Eur J Cardiothorac Surg · Pubmed #27130949.

ABSTRACT: -- No abstract --

10 Editorial The on-pump/off-pump saga: an enduring conundrum. 2016

Sousa Uva, Miguel / Kolh, Philippe. ·Department of Cardiothoracic Surgery, Hospital da Cruz Vermelha, Lisbon, Portugal. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liege, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26670805.

ABSTRACT: -- No abstract --

11 Editorial The radial artery for coronary artery bypass grafting: a second revival? 2016

Sousa Uva, Miguel / Kolh, Philippe. ·Department of Cardiothoracic Surgery, Hospital da Cruz Vermelha, Lisbon, Portugal. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, CHU Sart Tilman, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26286443.

ABSTRACT: -- No abstract --

12 Editorial Doing better in more complex patients: leading the way for QUIP. 2016

Osnabrugge, Ruben L / Kappetein, A Pieter / Head, Stuart J / Kolh, Philippe. ·Erasmus University Medical Center, Rotterdam, Netherlands. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26242898.

ABSTRACT: -- No abstract --

13 Editorial Structure and functioning of the Heart Team: primum non nocere. 2015

Stefanini, Giulio G / Kolh, Philippe. ·Cardiovascular Department, Humanitas Research Hospital, Rozzano, Milan, Italy. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #26242899.

ABSTRACT: -- No abstract --

14 Editorial Bilateral internal thoracic artery grafts for myocardial revascularization in insulin-dependent diabetic patients: time for wide clinical practice? 2015

Jatene, Fabio Biscegli / Kolh, Philippe. ·Cirurgia Cardiovascular, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #25501320.

ABSTRACT: -- No abstract --

15 Editorial Trans-Atlantic differences in coronary artery bypass grafting: is it the patient, the surgery or the health-care system? 2015

Uva, Miguel Sousa / Kolh, Philippe. ·Department of Cardiothoracic Surgery, Hospital da Cruz Vermelha, Lisbon, Portugal. · Department of Cardiothoracic Surgery, University Hospital of Liège, CHU Sart Tilman, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #25312532.

ABSTRACT: -- No abstract --

16 Editorial Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 2015

Stefanini, Giulio G / Windecker, Stephan / Kolh, Philippe. ·Department of Cardiology, Bern University Hospital, Bern, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, Sart Tilman, Liège, Belgium philippe.kolh@chu.ulg.ac.be. ·Eur J Cardiothorac Surg · Pubmed #25312531.

ABSTRACT: -- No abstract --

17 Editorial Analysis of on-pump and off-pump surgery in the Arterial Revascularization Trial. 2015

Poullis, Michael / Kolh, Philippe. ·Liverpool Heart and Chest Hospital, Liverpool, UK mpoullis@hotmail.com. · Department of Cardiovascular Surgery, University Hospital of Liege, CHU Sart Tilman, Liege, Belgium. ·Eur J Cardiothorac Surg · Pubmed #25217502.

ABSTRACT: -- No abstract --

18 Review Modality Selection for the Revascularization of Left Main Disease. 2019

Tam, Derrick Y / Bakaeen, Faisal / Feldman, Dmitriy N / Kolh, Philippe / Lanza, Gaetano Antonio / Ruel, Marc / Piccolo, Raffaele / Fremes, Stephen E / Gaudino, Mario. ·Division of Cardiac Surgery, Schulich Heart Centre, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Departments of Thoracic and Cardiovascular Surgery, Heart and Vascular Institutes, Cleveland Clinic, Cleveland, Ohio, USA. · Division of Cardiology, Weill Cornell Medical College, New York, New York, USA. · Department of Biomedical and Preclinical Sciences, University of Liège, Liège, Belgium. · Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore and Department of Cardiovascular and Thoracic Diseases, Rome, Italy. · Division of Cardiac Surgery, Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada. · Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Division of Cardiac Surgery, Schulich Heart Centre, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: Stephen.fremes@sunnybrook.ca. · Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore and Department of Cardiovascular and Thoracic Diseases, Rome, Italy; Department of Cardiothoracic Surgery, Weill Cornell Medical College, New York, New York, USA. ·Can J Cardiol · Pubmed #31277888.

ABSTRACT: The management of severe left main (LM) disease remains controversial and continues to evolve as new evidence emerges. Patient selection for coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) relies on both predicting mortality with CABG from clinical characteristics using the Society of Thoracic Surgeons (STS) risk score and anatomical complexity, using the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score. LM stenting techniques continue to evolve; for bifurcation lesions, the use of the double-kiss crush technique may reduce the incidence of late target vessel revascularization. In patients with acute coronary syndrome (ACS) complicated by cardiogenic shock, PCI is likely the first-line option in those with anatomically amenable disease, whereas all other stable non-ST-elevated ACS should be treated similar to stable ischemic heart disease. Outcomes comparing CABG and PCI have been recently examined in 2 large randomized clinical trials. In general, early outcomes of periprocedural myocardial infarction and stroke favoured PCI or were not different from outcomes with CABG. However, the conclusions of both trials are at present discordant with respect to late major adverse cardiac and cerebral events; additional follow-up of the trial patients is important for informed patient decision making. The appropriate mode of revascularization should be selected according to patient clinical characteristics and the complexity of the coronary lesions according to European and American guidelines. In those with low or intermediate SYNTAX scores, particularly with high surgical risk, PCI may be preferred to CABG in most other scenarios. A multidisciplinary heart team is recommended to help individualize revascularization decisions.

19 Review Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. 2017

Siller-Matula, Jolanta M / Petre, Alexandra / Delle-Karth, Georg / Huber, Kurt / Ay, Cihan / Lordkipanidzé, Marie / De Caterina, Raffaele / Kolh, Philippe / Mahla, Elisabeth / Gersh, Bernard J. ·1 Department of Cardiology, Medical University of Vienna, Austria. · 2 3rd Medical Department of Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria. · 3 Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria. · 4 Faculty of Pharmacy, University of Montreal; Research Center, Montreal Heart Institute, Canada. · 5 Institute of Cardiology, 'G d'Annunzio' University - Chieti-Pescara, Chieti, Italy. · 6 Department of Cardiothoracic Surgery, University Hospital of Liege, Belgium. · 7 Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Austria. · 8 Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, College of Medicine Rochester, USA. ·Eur Heart J Acute Cardiovasc Care · Pubmed #25943554.

ABSTRACT: OBJECTIVE: To review systematically the evidence and perform a meta-analysis of benefits and risks associated with use of P2Y RESULTS: Fifty-four studies met the selection criteria and included 50,048 patients. Preoperative use of clopidogrel on top of aspirin in patients undergoing coronary artery bypass graft was associated with a 2.5-fold increased risk of re-operation for bleeding (95% CI: 1.92-3.25; p<0.001) and a 1.47-fold increased risk of death (95% CI: 1.25-1.72; p<0.001), but did not diminish the risk for myocardial infarction (RR: 0.96; 95% CI: 0.75-1.25; p=0.18) or MACE (RR: 1.16; 95% CI: 0.90--1.50; p=0.30). In patients undergoing non-cardiac surgery, preoperative use of clopidogrel increased the RR of re-operation for major bleeding by 2.05-fold (95% CI: 1.13-3.73; p=0.002) but did not reduce the RR for MACE or death. Clopidogrel use during cardiac device implantation raised the RR for procedure-related haematoma by 3.0-fold (95% CI: 1.30--6.94; p=0.001). Whereas preoperative ticagrelor use did not increase the risk for mortality (RR: 1.03; 95% CI: 0.49-2.14), preoperative prasugrel use tended to increase the risk for death (RR: 5.06; 95% CI: 0.54-47.65). CONCLUSION: Preoperative exposure to clopidogrel on top of aspirin did not reduce the risk of MACE but was associated with increased risk of bleeding and mortality.

20 Article Analyse the evidence, generate new evidence and apply the evidence: cardiac surgery is not only about cutting and sewing. 2020

Gaudino, Mario / Schwann, Thomas / Puskas, John / Kolh, Philippe. ·Department of Cardiothoracic Surgery, Cornell University, New York, NY, USA. · Department of Cardiothoracic Surgery, University of Massachusetts-Baystate, Springfield, MA, USA. · Department of Cardiovascular Surgery, Mount Sinai Saint Luke's, New York, NY, USA. · Department of Biomedical and Preclinical Sciences, University of Liège, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #31435673.

ABSTRACT: -- No abstract --

21 Article The jury is still out on the use of bilateral internal thoracic arteries in coronary surgery. 2019

Gaudino, Mario / Fremes, Stephen / Kolh, Philippe. ·Department of Cardiothoracic Surgery, Cornell University, New York, NY, USA. · Division of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Department of Biomedical and Preclinical Sciences, University of Liège, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #30476029.

ABSTRACT: -- No abstract --

22 Article Geographical differences in the ratio of percutaneous and surgical myocardial revascularization procedures in the treatment of coronary artery disease. 2017

Piccolo, Raffaele / Windecker, Stephan / Kolh, Philippe. ·Department of Cardiology, Bern University Hospital, Inselspital, Bern, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, CHU Sart Tilman, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #28874028.

ABSTRACT: -- No abstract --

23 Article Percutaneous coronary interventions with second-generation drug-eluting stent versus off-pump coronary artery bypass grafting: mid-term results. 2017

Berdajs, Denis / Kolh, Philippe. ·Division of Cardiac Surgery, University Hospital Basel, Basel, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liège, CHU Sart Tilman, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #28874026.

ABSTRACT: -- No abstract --

24 Article Myocardial revascularization in patients with left main or multivessel coronary artery disease at high surgical risk: conventional wisdom versus risk prediction model. 2017

Piccolo, Raffaele / Windecker, Stephan / Kolh, Philippe. ·Department of Cardiology, Bern University Hospital-Inselspital, Bern, Switzerland. · Department of Cardiovascular Surgery, University Hospital (CHU, ULg) of Liege, CHU Sart Tilman, Liège, Belgium. ·Eur J Cardiothorac Surg · Pubmed #28329202.

ABSTRACT: -- No abstract --

25 Article Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. 2014

Windecker, Stephan / Stortecky, Stefan / Stefanini, Giulio G / da Costa, Bruno R / Rutjes, Anne Wilhelmina / Di Nisio, Marcello / Silletta, Maria G / Maione, Ausilia / Alfonso, Fernando / Clemmensen, Peter M / Collet, Jean-Philippe / Cremer, Jochen / Falk, Volkmar / Filippatos, Gerasimos / Hamm, Christian / Head, Stuart / Kappetein, Arie Pieter / Kastrati, Adnan / Knuuti, Juhani / Landmesser, Ulf / Laufer, Günther / Neumann, Franz-Joseph / Richter, Dimitri / Schauerte, Patrick / Sousa Uva, Miguel / Taggart, David P / Torracca, Lucia / Valgimigli, Marco / Wijns, William / Witkowski, Adam / Kolh, Philippe / Jüni, Peter. · ·BMJ · Pubmed #24958153.

ABSTRACT: OBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease. DESIGN: Bayesian network meta-analyses to combine direct within trial comparisons between treatments with indirect evidence from other trials while maintaining randomisation. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: A strategy of initial medical treatment compared with revascularisation by coronary artery bypass grafting or Food and Drug Administration approved techniques for percutaneous revascularization: balloon angioplasty, bare metal stent, early generation paclitaxel eluting stent, sirolimus eluting stent, and zotarolimus eluting (Endeavor) stent, and new generation everolimus eluting stent, and zotarolimus eluting (Resolute) stent among patients with stable coronary artery disease. DATA SOURCES: Medline and Embase from 1980 to 2013 for randomised trials comparing medical treatment with revascularisation. MAIN OUTCOME MEASURE: All cause mortality. RESULTS: 100 trials in 93,553 patients with 262,090 patient years of follow-up were included. Coronary artery bypass grafting was associated with a survival benefit (rate ratio 0.80, 95% credibility interval 0.70 to 0.91) compared with medical treatment. New generation drug eluting stents (everolimus: 0.75, 0.59 to 0.96; zotarolimus (Resolute): 0.65, 0.42 to 1.00) but not balloon angioplasty (0.85, 0.68 to 1.04), bare metal stents (0.92, 0.79 to 1.05), or early generation drug eluting stents (paclitaxel: 0.92, 0.75 to 1.12; sirolimus: 0.91, 0.75 to 1.10; zotarolimus (Endeavor): 0.88, 0.69 to 1.10) were associated with improved survival compared with medical treatment. Coronary artery bypass grafting reduced the risk of myocardial infarction compared with medical treatment (0.79, 0.63 to 0.99), and everolimus eluting stents showed a trend towards a reduced risk of myocardial infarction (0.75, 0.55 to 1.01). The risk of subsequent revascularisation was noticeably reduced by coronary artery bypass grafting (0.16, 0.13 to 0.20) followed by new generation drug eluting stents (zotarolimus (Resolute): 0.26, 0.17 to 0.40; everolimus: 0.27, 0.21 to 0.35), early generation drug eluting stents (zotarolimus (Endeavor): 0.37, 0.28 to 0.50; sirolimus: 0.29, 0.24 to 0.36; paclitaxel: 0.44, 0.35 to 0.54), and bare metal stents (0.69, 0.59 to 0.81) compared with medical treatment. CONCLUSION: Among patients with stable coronary artery disease, coronary artery bypass grafting reduces the risk of death, myocardial infarction, and subsequent revascularisation compared with medical treatment. All stent based coronary revascularisation technologies reduce the need for revascularisation to a variable degree. Our results provide evidence for improved survival with new generation drug eluting stents but no other percutaneous revascularisation technology compared with medical treatment.

Next